Literature DB >> 9855143

Endophthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history: a retrospective case-control study.

P G Montan1, G Koranyi, H E Setterquist, A Stridh, B T Philipson, K Wiklund.   

Abstract

OBJECTIVE: This study aimed to investigate the relationship between postoperative endophthalmitis and current changes in the cataract operative technique.
DESIGN: A retrospective case-control study. PARTICIPANTS: The 22,091 cataract operations performed from 1990 through 1993 at St Eriks Hospital formed the basis for this investigation. In a random fashion, 220 control subjects were selected to be compared with the endophthalmitis cases. MAIN OUTCOME MEASURES: Numerous variables pertaining to the cataract extraction procedure and to the ocular and general health of patients with cataracts were analyzed regarding the development of postoperative intraocular infection. Patient age, presence of diabetes or immunosuppression, type of cataract extraction and intraocular lens (IOL), and intraoperative or postoperative complications were the principal variables assessed.
RESULTS: Fifty-seven patients with endophthalmitis were diagnosed, resulting in an overall frequency of 0.26%. Immunosuppressive treatment (P = 0.019), wound abnormality (P = 0.03), and the use of IOLs without a heparinized surface (P = 0.0023) were the only significant risk factors found in a logistic regression model.
CONCLUSIONS: The results suggest that cataract operating practice may alter the risk for endophthalmitis in that implanting a heparinized IOL and creating a tight section both seem to provide protection against this dreaded complication. Regarding patient history, an increased susceptibility was found among subjects treated with immunosuppressants. Designing a prophylactic protocol that protects against endophthalmitis more efficiently than did the study prophylaxis of 20 mg of subconjunctival gentamicin, is important not only for this patient subgroup but also for the cataract operated population at large.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855143     DOI: 10.1016/S0161-6420(98)91211-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  29 in total

1.  Infectious Endophthalmitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

2.  Pharmacokinetics of subconjunctival injection of moxifloxacin in humans.

Authors:  Kazuki Matsuura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-03       Impact factor: 3.117

3.  Comprehensive Review of the Effects of Diabetes on Ocular Health.

Authors:  Kathryn Skarbez; Yos Priestley; Marcia Hoepf; Steven B Koevary
Journal:  Expert Rev Ophthalmol       Date:  2010-08-01

4.  TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus.

Authors:  Nazeem Shamsuddin; Ashok Kumar
Journal:  J Immunol       Date:  2011-05-20       Impact factor: 5.422

5.  [Lavasept as an alternative to PVP-iodine as a preoperative antiseptic in ophthalmic surgery. Randomized, controlled, prospective double-blind trial].

Authors:  F Hansmann; A Kramer; H Ohgke; H Strobel; M Müller; G Geerling
Journal:  Ophthalmologe       Date:  2005-11       Impact factor: 1.059

6.  Endophthalmitis following cataract surgery in southwest Finland from 1987 to 2000.

Authors:  Timo T Haapala; Laura Nelimarkka; Jukka M Saari; Virpi Ahola; K Matti Saari
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

7.  Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.

Authors:  D A M Lyall; A Tey; B Foot; S T D Roxburgh; M Virdi; C Robertson; C J MacEwen
Journal:  Eye (Lond)       Date:  2012-10-12       Impact factor: 3.775

8.  Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

Authors:  M Kernt; A Kampik
Journal:  Clin Ophthalmol       Date:  2010-03-24

9.  [Polyhexamethylbiguanid (PHMB) as preoperative antiseptic for cataract surgery].

Authors:  F Hansmann; A Kramer; H Ohgke; H Strobel; M Müller; G Geerling
Journal:  Ophthalmologe       Date:  2004-04       Impact factor: 1.059

10.  Pathogenic conjunctival bacteria associated with systemic co-morbidities of patients undergoing cataract surgery.

Authors:  M-E Fernández-Rubio; T Cuesta-Rodríguez; J-L Urcelay-Segura; C Cortés-Valdés
Journal:  Eye (Lond)       Date:  2013-05-24       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.